Can babies get RSV protection and routine shots at the same visit? new study aims to find out.

NCT ID NCT07158814

Recruiting now Prevention Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving infants an RSV preventive antibody at the same time as their regular vaccines is safe. About 524 babies aged 6 weeks to under 30 weeks will take part. Researchers will compare fever rates in babies who get the RSV shot together with vaccines versus those who get them on separate days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVERSE EVENT FOLLOWING IMMUNISATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fever respiratory syncytial virus infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVERSE EVENT FOLLOWING IMMUNISATION FEVER

Contacts and locations

Locations

Centers for Disease Control and Prevention
ACTIVE_NOT_RECRUITING

Atlanta, Georgia, 30333, United States
Cincinnati Children's Hospital Medical Center
RECRUITING

Cincinnati, Ohio, 45229, United States
Columbia University
RECRUITING

New York, New York, 10027, United States
Duke University
RECRUITING

Durham, North Carolina, 27710, United States
Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Kaiser Permanente Northern California
RECRUITING

Oakland, California, 94612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.